<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Estonia</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Estonia.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/ee.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Sat, 07 Nov 2026 03:45:11 GMT</lastBuildDate>
  <item>
    <title>Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1001932-a373ddff/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1001932-a373ddff/</guid>
    <pubDate>Tue, 29 Dec 2015 00:00:00 GMT</pubDate>
    <description>The findings suggest that regimen composition and rapid access to high-quality drug susceptibility testing may be important considerations when designing individualized multidrug-resistant tuberculosis treatment. The authors state that randomized trials are needed to determine whether individualized regimens with more than five drugs improve cure outcomes.</description>
    <category>Tuberculosis</category>
    <category>Multidrug-resistant tuberculosis</category>
    <category>Treatment</category>
    <category>Antimicrobial resistance</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-2471-blt-11-092585-b8a604d8/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-2471-blt-11-092585-b8a604d8/</guid>
    <pubDate>Mon, 07 Nov 2011 00:00:00 GMT</pubDate>
    <description>Documented high MDR-TB burden and unclear trends show a need for improved surveillance, particularly in Africa and India.</description>
    <category>Tuberculosis</category>
    <category>Multidrug-resistant tuberculosis</category>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Antimicrobial resistance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>HIV/AIDS surveillance in Europe: update 2007</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-2807-ese-13-50-19066-en-4e32b863/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-2807-ese-13-50-19066-en-4e32b863/</guid>
    <pubDate>Thu, 11 Dec 2008 00:00:00 GMT</pubDate>
    <description>Surveillance data are described as vital for tracking HIV epidemic trends and evaluating public health responses in Europe.</description>
    <category>AIDS</category>
    <category>HIV infection</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
